pushing greatness into the world
very excited to launch Vercel X today, our six week accelerator program
if you're in the early stages of building (even as early as day -1), apply to join our SF cohort next Jan to March 2027
https://t.co/d0A6Xgqrms
I've gotten to know Dez through our work together on Rain and Velocity, and when he asked me to come on his podcast I jumped at the chance. Incredibly thoughtful interview talking about all things venture capital.
In our lord’s year of 2026 you can’t be in VC without some kind of content game, so we’re keeping the momentum going with The Longest View!!!
I am super pumped to share another episode of the show, this time with my friend @HadickM.
Fun fact about Rob: he loves house music/EDM, so you should ask him who some of his favorite DJs are. In this episode, Rob and I talk about his career in venture so far, what his most successful investments have looked like to date (we get into this directly in the clip below), and perps access in the US. Hint hint, wink wink: his views were very prescient, given we recorded this pod back in August.
In any event, this is a wide-ranging discussion on how to build a career in venture, how to take thoughtful risks, and a view into what GPs are thinking about today as the world revolves around compute, inference, and agentic capabilities. Take a listen when you can, and per usual, I’m open to any feedback!!
Building intelligence that compounds: excited to announce our investment in @remanencelabs and partner with @plcedoz, @hparams and Axel Moyal - a $30M seed co-led with @eqt.
More on continual learning and the thesis here:
https://t.co/RvHyxj2gOo
Today we’re announcing Remanence and our $30M seed round, co-led by EQT Ventures and FirstMark.
AI agents generate data on every tool call, failure and correction. Almost all of it is thrown away, and the next run makes the same mistakes at the same cost. 🧵
Proud to announce our investment in @Remanence, co-leading their $30M seed alongside @EQTVentures, with support from angels @oliveur, @pcorrot, @romain_pigment, @EleonorePigment, @vriparbelli, and @Stjerrild.
Most companies running AI agents throw away the data on how their work actually gets done. Remanence turns those agent traces into training environments, then post-trains open-weight models that each company owns.
Welcome to the FirstMark family @plcedoz, @hparams, and Axel Moyal 🚀
Check out https://t.co/TTMW5rpuWR to learn more!
Thrilled to host @RilletHQ’s Women in Finance Night at FirstMarkHQ, featuring OpenAI, Rogo, and ButterflyMX 🚀
Proud to see such a phenomenal community come together to meet, learn, and support each other.
$270M to $3B+, with fewer people than we had in 2021. The proudest work of my career, alongside the best team I know.
The point was never fewer people. It was more for patients: helping millions reach their health goals, for less.
It’s so cool to read stories like this.
Two of my smartest friends from college have been at Ro for a long time, unsurprising that they pulled it off but $3B is no joke!
In 2021, Ro was growing 9% annually with a $270M revenue run rate.
Today, it's at $3B+ with fewer employees than it had five years ago. ARR per employee has increased more than 10x.
@ZReitano shares how they refounded the company in 2022 and what changed.
Have listened and learned from @patrick_oshag and his guests for years. When I decided to do this conversation, I went straight to him. Hope you enjoy it.
Still just the beginning!
Nine years ago, we set out to put patients at the center of healthcare. Today, @ZReitano shared that @ro has passed $3B in ARR.
For us, this means patients want healthcare that's simpler and more accessible, and they've shown up in numbers that are hard to ignore. We've helped millions of patients, in virtually every county in America.
But a milestone isn't a destination. $3B is the proof that the model works, and clear evidence that we've built a brand and a platform that patients deeply trust. We're so thrilled to continue building on this foundation with our patients front and center!
https://t.co/KCtN4js8BC
Tenacious, ambitious and incredibly principled… truly one of a kind founder. Proud of @ZReitano for telling the story that is really just beginning. Let’s go @ro!
In 4 years, we've grown Ro's revenue 10x. Today we passed $3B ARR — with fewer employees than we had in 2021.
Since our refounding, the team has locked in every single day. With maniac levels of focus.
Grateful to fight for patients alongside @ZReitano and the entire @ro team.
We're just getting started. Wait until you see 2027.
🚀
@ZReitano is a singular founder and this ep is MUST listen 👇
@ro has helped millions become healthier and happier, and the company journey is full of twists and turns that every builder can learn valuable lessons from.
Incredibly proud to have backed Z and the Ro team from day one!
My conversation with Zach Reitano (@ZReitano), co-founder and CEO of Ro
In four years he took Ro from a $250M run rate to over $3B, with about a third fewer people
Zach rarely does long conversations like this, so it was fun to talk about the details of what that took and everything happening in healthcare
Plus, his answer to the closing question is amazing
We discuss:
- the state of the US healthcare system
- refounding Ro
- strong attract, strong repel culture
- the notion of jobs over lives
- the power of celebrities in marketing
- the importance of tailwinds (AI, GLP-1s)
- trying to recreate his dad in software
Enjoy!
TIMESTAMPS
0:34 How Much Should We Spend on Health
4:59 The Patient Is Not the Customer
10:24 Inside Ro's Business
18:28 The Future of GLP-1s
25:46 Jobs Over Lives
30:02 The Turnaround
47:43 Where Healthcare Goes Next
1:00:27 Recreating His Dad in Software
1:06:33 Marketing Into Stigma
1:19:06 Zach's Hottest Take
1:20:58 The Kindest Thing